Search - tctmd.com

Displaying 21 - 40 of 40

Sort: Relevancy | Date

Presentation TCT 2016

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

Presenter: Chaim S. Lotan, Giora Weisz

October 31, 2016

Presentation TCT 2016

Complex Coronary Lesions II: CTO, SVGs

Presenter: Emmanouil S. Brilakis, Kevin J. Croce

October 30, 2016

Presentation TCT 2016

Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation

Presenter: Barry D. Rutherford, Gerard T. Wilkins, Colm Hanratty

October 30, 2016

Presentation TCT 2016

Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium

Presenter: Barry D. Rutherford, Gerard T. Wilkins, Masahisa Yamane

October 30, 2016

Presentation TCT 2016

Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF

Presenter: Barry D. Rutherford, Gerard T. Wilkins, James M. McCabe

October 30, 2016

Presentation TCT 2016

Limitations of Pharmacotherapy in Complicated PCI Anatomy (Diffuse CAD, Bifurcations, CAD, Calification, SVG, CTO, etc.)

Presenter: Sorin J. Brener, Franz-Josef Neumann, Usman Baber

October 30, 2016

Presentation Fellows 2016

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Dimitrios Karmpaliotis, Manish A. Parikh

April 16, 2016

Presentation JIM 2016

'Large Vessels: LM-SVG'

Presenter: Robert-Jan van Geuns

February 09, 2016

Presentation TCT 2015

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Presenter: Jeffrey W. Moses, Erick Schampaert, Dimitri Karmpaliotis

October 14, 2015

Presentation TCT 2015

Complex Coronary Lesions (Left Main, Bifurcations, CTO, and SVGs)

Presenter: George D. Dangas, Tayo A. Addo

October 11, 2015

Presentation

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

Presenter: J. Matthew Brennan

July 17, 2015

Presentation Fellows 2015

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish A. Parikh, Tamim Nazif

May 16, 2015

Presentation TCT 2014

Complex Coronary Lesions (Left Main, Bifurcations, CTO, SVGs)

Presenter: George D. Dangas, Tayo A. Addo

September 13, 2014

Presentation Fellows 2014

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Presenter: Manish Parikh

April 13, 2014

Presentation

The Dark Side of SVG

Presenter: Ezri Rozenbaum

December 02, 2013

Presentation TCT 2013

Complex Coronary Lesions (Left Main, Bifurcations, CTO, SVGs)

Presenter: Tayo Addo

October 27, 2013

Presentation SOLACI 2013

SVG Interventions: Progress or Dead-End?

Presenter: Conrad Simpfendorfer

July 26, 2013

Presentation

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Presenter: A. Sachdeva

November 13, 2012

Presentation TCT 2012

Treatment of Multiple Huge SVG Aneurysms: Stent or Surgery?

Presenter: Kristina Maric

October 24, 2012

Presentation TCT 2012

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee

January 03, 2012

Advertisement

Acute MI/SVGS/Thrombus Containing Lesions: Mesh-Covered Mguard Prime

Complex Coronary Lesions II: CTO, SVGs

Case #4: Patent but Diseased SVG Used as a Conduit for Salvaging the Native Circulation

Case #3: SVG Occlusion With Heavily Calcified Native Vessel CTO With Viable Myocardium

Case #2: Recurrent SVG-LAD In-Stent Restenosis With LMCA CTO and Low EF

Limitations of Pharmacotherapy in Complicated PCI Anatomy (Diffuse CAD, Bifurcations, CAD, Calification, SVG, CTO, etc.)

Thrombectomy, Embolic Protection Systems, and SVG Intervention

'Large Vessels: LM-SVG'

SVG Intervention: Is Distal Protection Still Needed? And Should We Always Do the Native Vessel Instead?

Complex Coronary Lesions (Left Main, Bifurcations, CTO, and SVGs)

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

Thrombectomy, Embolic Protection Systems, and SVG Intervention

Complex Coronary Lesions (Left Main, Bifurcations, CTO, SVGs)

Thrombectomy, Embolic Protection Systems, and SVG Intervention

The Dark Side of SVG

Complex Coronary Lesions (Left Main, Bifurcations, CTO, SVGs)

SVG Interventions: Progress or Dead-End?

Discontinuation of Long-term Clopidogrel Therapy Is Associated with Death and MI After SVG PCI

Treatment of Multiple Huge SVG Aneurysms: Stent or Surgery?

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content